Friday, April 24, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Banking & Insurance

Allianz Races Toward Record Territory as Goldman Sachs Turns Bullish and India Deal Closes

SiterGedge by SiterGedge
April 24, 2026
in Banking & Insurance, Mergers & Acquisitions, Renewable Energy
0
Allianz Stock
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

The Allianz share price is closing in on levels not seen since the dot-com era, propelled by a powerful analyst upgrade from Goldman Sachs and the finalisation of a strategic joint venture in India. The stock, which has gained nearly 11 percent over the past month, now trades just above 390 euros — within striking distance of its all-time high from the year 2000.

Goldman Sachs analyst Andrew Baker has fundamentally reassessed the insurer’s prospects, upgrading the stock from “Neutral” to “Buy” and lifting the price target to 450 euros. In a note that pushed back against prevailing market anxieties, Baker argued that concerns over the company’s exposure to private credit are overblown, representing only a fraction of the group’s total market value. He also dismissed fears that artificial intelligence would disrupt Allianz’s business model, contending instead that the technology offers a genuine opportunity to enhance profitability in a challenging operating environment.

The bullish call from Wall Street arrives as Allianz locks in operational progress on the ground. On April 22, the group confirmed a binding agreement with Jio Financial Services to establish a 50-50 joint venture targeting India’s fast-expanding primary insurance market. The new entity will focus on property and casualty coverage as well as health insurance, giving Allianz a direct channel into one of the world’s most dynamic economies. Analysts at RBC, led by Ben Cohen, have already incorporated the expected earnings contribution from the partnership into their first-quarter estimates, maintaining a price target of 400 euros and a “Sector Perform” rating.

Should investors sell immediately? Or is it worth buying Allianz?

On the domestic front, Allianz is also scaling up its commitment to green infrastructure. Its asset management arm, Allianz Global Investors, has acquired a 51 percent stake in Green Energy Storage Initiative (GESI), a developer of digitalised large-scale battery storage systems. GESI is currently building three major projects in Bavaria and Lower Saxony with a combined grid connection capacity of roughly 2.6 gigawatts, placing them among Germany’s largest storage facilities. The move aligns with the group’s strategy of coupling climate protection with infrastructure investments that offer attractive returns.

The operational backdrop for this flurry of activity is robust. Allianz posted a record operating profit of 17.4 billion euros in the last financial year and has guided for a similar result in 2026. Shareholders now have two key dates on the horizon. At the annual general meeting on May 7, the board is proposing a dividend of 17.10 euros per share — an 11 percent increase year-on-year. Also on the agenda is a reform of executive compensation, which is set to be more tightly linked to sector performance.

The first real test of whether the momentum can be sustained comes on May 13, when Allianz publishes its first-quarter results. Market participants will be scrutinising the numbers for the financial impact of the recent acquisitions and the joint venture in India. If the operating strength continues, the 52-week high of just under 395 euros — already tested in recent sessions — may soon be revisited, with the all-time high from the turn of the millennium firmly in the crosshairs.

Ad

Allianz Stock: Buy or Sell?! New Allianz Analysis from April 24 delivers the answer:

The latest Allianz figures speak for themselves: Urgent action needed for Allianz investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 24.

Allianz: Buy or sell? Read more here...

Tags: Allianz
SiterGedge

SiterGedge

Related Posts

BayWa Stock
Banking & Insurance

BayWa’s €2.7 Billion Gap Widens as Bank Deadline Looms and Legal Troubles Mount

April 24, 2026
Nel ASA Stock
Earnings

Nel ASA: New Platform Launch and US Utility Win Offer Counterweight to Order Slump

April 24, 2026
BASF Stock
Chemicals

BASF’s April 30 Crossroads: A Spin-Off Vote, Q1 Earnings, and a Bullish Wall Street Call

April 24, 2026
Next Post
BioNTech Stock

BioNTech's ADC Breakthrough Fuels Rally as Oncology Pivot Gathers Pace

Voestalpine Stock

Voestalpine Forges Ahead on Two Fronts: Rail Megadeals and Chemical-Free Coatings

Hensoldt Stock

Hensoldt’s Execution Test: Can Record Orders Become Real Revenue?

Recommended

Exxon Mobil Stock

Can Exxon Mobil Navigate the Oil Price Downturn?

6 months ago
Food Producers Stock Market Today

Plantify Foods Expands Partnership in Israel with New Retailer

2 years ago
Vulcan Energy Stock

Lithium Developer Vulcan Energy Sees Shares Slide Despite Major ABB Contract

5 months ago
NASDAQ 100 Stock

Tech Stocks Drive Nasdaq 100 Toward Historic 25,000 Threshold

7 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Newmont Mining Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

DroneShield’s A$2.4 Billion Production Target Hinges on Pipeline Conversion

Novo Nordisk’s Washington Shuffle and Teen Pill Progress Mask a Grim Market Reality

XRP’s Quantum Leap and DeFi Debut Clash With Legislative Gridlock

Wolfram’s New Calculus: Almonty’s Options Surge Meets a Production Reality Check

Hensoldt’s Execution Test: Can Record Orders Become Real Revenue?

Voestalpine Forges Ahead on Two Fronts: Rail Megadeals and Chemical-Free Coatings

Trending

BayWa Stock
Banking & Insurance

BayWa’s €2.7 Billion Gap Widens as Bank Deadline Looms and Legal Troubles Mount

by Kennethcix
April 24, 2026
0

The clock is ticking for BayWa. By the end of April, the German agricultural and energy group...

Nel ASA Stock

Nel ASA: New Platform Launch and US Utility Win Offer Counterweight to Order Slump

April 24, 2026
ServiceNow Stock

ServiceNow’s AI Surge Hits $1.5 Billion, Yet Investors Punish the Stock for What’s Missing

April 24, 2026
DroneShield Stock

DroneShield’s A$2.4 Billion Production Target Hinges on Pipeline Conversion

April 24, 2026
Novo Nordisk Stock

Novo Nordisk’s Washington Shuffle and Teen Pill Progress Mask a Grim Market Reality

April 24, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BayWa’s €2.7 Billion Gap Widens as Bank Deadline Looms and Legal Troubles Mount
  • Nel ASA: New Platform Launch and US Utility Win Offer Counterweight to Order Slump
  • ServiceNow’s AI Surge Hits $1.5 Billion, Yet Investors Punish the Stock for What’s Missing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com